Glazer Capital, LLC Ibere Pharmaceuticals Transaction History

Glazer Capital, LLC

$1.29 Billion
Q2 2024

Shares

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 14, 2023	BUY	$9.93 - $10.09 $2.42 Million - $2.46 Million	243,601 Added 22.42%	1,330,102 $13.4 Million
Q3 2022 Nov 14, 2022	BUY	$0.11 - $9.94 $63,422 - $5.73 Million	576,567 Added 113.07%	1,086,501 $10.8 Million
Q2 2022 Aug 15, 2022	BUY	$9.77 - $9.84 $3.24 Million - $3.26 Million	331,439 Added 185.69%	509,934 $5 Million
Q1 2022 May 17, 2022	SELL	$9.69 - $9.81 $83,547 - $84,581	-8,622 Reduced 4.61%	178,495 $1.75 Million
Q4 2021 Feb 14, 2022	BUY	$9.68 - $9.77 $1.71 Million - $1.72 Million	176,529 Added 1667.26%	187,117 $1.81 Million
Q3 2021 Nov 15, 2021	SELL	$9.61 - $9.78 $4,776 - $4,860	-497 Reduced 4.48%	10,588 $103,000
Q2 2021 Aug 13, 2021	BUY	$9.65 - $9.95 $106,970 - $110,295	11,085 New	11,085 $107,000

Others Institutions Holding IBER

# of Institutions

1

Shares Held

0

Call Options Held

0

Put Options Held

0

Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

About IBERE PHARMACEUTICALS

Ticker IBER
Exchange NYSE
Sector Financial Services
Industry Shell Companies
Shares Outstandng 13,800,000
Description
Ibere Pharmaceuticals does not have significant operations. It focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Philadelphia, Pennsylvania.

More about IBER

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glazer Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Glazer Capital, LLC with notifications on news.